When kids come to us with obsessive-compulsive disorder (OCD), we know that first-line treatment is cognitive behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRIs). But then what? What about the kids who don’t respond to CBT or SSRIs? This research update discusses studies measures, treatments and medications for to take to help your younger OCD patients.

In March 2015, the US Food and Drug Administration (FDA) approved Actavis’ asenapine (Saphris) for the acute treatment of manic or mixed episodes associated with bipolar disorder in kids between 10 and 17 years.

After reading these articles, you should be able to…

When most of us went to school, we knew who the bullies were, and we knew who got bullied, but the problem was not discussed much. Things have changed since then. With media coverage of suicides attributable to bullying, we now realize that the phenomenon is potentially deadly.

Get some practical advice on how child psychiatrists can work with teachers to address behavioral problems in students, in an interview with Jessica Minahan, MEd, BCBA, an author and director of behavioral services at Neuropsychology & Education Services for Children and Adolescents in Newton, MA.

Learn how to combine medications and behavior techniques to help schools work with challenging students, in an interview with Nancy Rappaport, MD, Attending Child and Adolescent Psychiatrist, Cambridge Health Alliance, where she is director of school-based programs.

After reading these articles, you should be able to…

There is a lack good research on the best ways to calm acutely agitated children. Your approach may likely be slightly different from a colleague’s. Here are some suggestions to help when you find yourself in situations where nothing else works.

Get some practical tips for how to handle psychiatric emergencies in children and adolescents, in an interview with Ruth S. Gerson, MD, director of Bellevue Hospital Children’s Comprehensive Psychiatric Emergency Program.

A new study on the safety and efficacy of Symbyax (olanzapine/fluoxetine combination or OFC) in kids with bipolar I depression is in press and will be published soon.